Shilpa Medicare Limited

BSE: 530549 NSE: SHILPAMED
Shilpa Medicare Limited - pharma in Raichur, Karnataka, India. FY 2026 financials and compliance.
CIN L85110KA1987PLC008739 Incorporated 20 November 1987 ROC Bangalore HQ Raichur, Karnataka, India
Active Listed - NSE: SHILPAMED · BSE: 530549 Public Limited Company pharma
Data last updated
Revenue · FY 2026
₹1,538.87 Cr
▲ 19.62% YoY
Computed EBITDA · FY 2026
₹444.54 Cr
▲ 30.67% YoY
Net profit · FY 2026
₹243.33 Cr
▲ 210.79% YoY
Authorised capital
₹59 Cr
Registered with MCA
Paid-up capital
₹19.56 Cr
Issued & subscribed
Open charges
₹122.8 Cr
Satisfied ₹1,670.23 Cr
Company age
39 yrs
Est. 1987
Employees · EPFO
930
Latest available

About Shilpa Medicare Limited

Data last updated: 15 July 2026

Shilpa Medicare Limited is a public limited company based in Raichur, Karnataka, India. It specialises in pharma contract r and d, a part of the broader pharmaceuticals sector. Incorporated on 20 November 1987, the company has been in operation for over 39 years.

Registered with ROC Bangalore under CIN L85110KA1987PLC008739. Listed on BSE: 530549 and NSE: SHILPAMED.

Capital: an authorised share capital of ₹59 Cr and a paid-up capital of ₹19.56 Cr. It is led by directors including Om Prakash Inani and Kalakota Reddy Sharath.

Last AGM: 23 September 2025. Financial statements filed for year ended 31 March 2025. Office: #12 – 6 – 214/A1 Hyderabad Road, Raichur, Karnataka, India – 584135.

As per NSE-filed consolidated financials for FY 2026, the company reported a revenue of ₹1,538.87 Cr, a growth of 19.62% compared to the previous year. The net worth stands at ₹2,591.2 Cr (up 9.62% YoY). Total assets are valued at ₹3,705.61 Cr (up 11.93% YoY).

The company has a workforce of approximately 930 employees as per the latest available data. Its group structure includes 7 subsidiaries and 2 joint ventures.

The company is associated with 3 brands - Shilpabio, Shilpa Therapeutics, Shilpa Medicare. As per MCA filings, the company has open charges of ₹122.8 Cr and satisfied charges of ₹1,670.23 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website vbshilpa.com.

Company Details of Shilpa Medicare Limited
CIN L85110KA1987PLC008739
Registration Number 008739
Incorporation Date 20 November 1987
ROC Bangalore
Listing Status Listed (BSE: 530549, NSE: SHILPAMED)
Company Status Active
Date of Last AGM 23 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Vishnukanth Chaturbhuj Bhutada Managing Director Kalakota Reddy Sharath Whole-Time Director Om Prakash Inani Director
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    vbshilpa.com
  • Social Media
  • Registered Address
    #12 – 6 – 214/A1 Hyderabad Road, Raichur, Karnataka, India – 584135
  • Industry
    Pharma, Pharma Contract R&D, API Manufacturers
Company report
Shilpa Medicare Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Shilpa Medicare Limited report

Financials, compliance, directors, charges, ownership and filings for Shilpa Medicare Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Shilpa Medicare Limited

Shilpa Medicare Limited has one previous CIN (Corporate Identification Number): U85110KA1987PLC008739. The current CIN is L85110KA1987PLC008739, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
L85110KA1987PLC008739 Current
U85110KA1987PLC008739 Previous

Associated Brands with Shilpa Medicare Limited

Shilpa Medicare Limited operates multiple associated brands including shilpabio, Shilpa Therapeutics, and Shilpa Medicare. These brands represent Shilpa Medicare Limited's diversified market presence and brand portfolio.

Brand Description Website
shilpabio
Develops biopharmaceuticals, biosimilars, and offers CDMO services for global customers. shilpabio.com
Shilpa Therapeutics
Develops innovative technologies for orally disintegrating strips in pharmaceuticals. shilpatherapeutics.com
Shilpa Medicare
APIs, fine chemicals, intermediates, and formulations are manufactured. vbshilpa.com

Competitors & Alternatives of Shilpa Medicare Limited

Brands and companies operating in the same space as Shilpa Medicare Limited include Inventia Healthcare, KBI Biopharma, Aldevron and 7 more.

Competitor Description Location Founded
Inventia Healthcare Inventia Healthcare Oral solid drug delivery systems are manufactured and developed. Mumbai, India, India 1985
KBI Biopharma KBI Biopharma Provider of protein formulation, process & cell line development, and cGMP services Durham, United States, United States 1996
Aldevron Aldevron Developer and custom manufacturer of nucleic acids, proteins and antibodies for research, clinical and commercial applications Fargo, United States, United States 1998
Ovagen Ovagen Provider of germ-free and specific pathogen free production of eggs for vaccine and antibody manufacturing services Mayo, Ireland, Ireland 2000
Omnia Biologics Omnia Biologics Process development and manufacturing services for biologics are provided. Rockville, United States, United States 2001
Laurus Bio Laurus Bio Precision fermentation services for biopharma and food are provided. Bengaluru, India, India 2005
Zim Labs Zim Labs Solid and semisolid dosage forms are developed and manufactured. Nagpur, India, India 1989
Kemwell Biopharma Kemwell Biopharma Integrated biologics development and manufacturing are provided as a CDMO. Bengaluru, India, India 1980
Lotus Lotus Contract manufacturing for oral solid formulations is offered. Taipei, Taiwan, Taiwan 1966
Eurogentec Eurogentec Oligonucleotides, peptides, and antibodies are developed and manufactured by Eurogentec. Seraing, Belgium, Belgium 1985

Business Activity of Shilpa Medicare Limited

Shilpa Medicare Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Shilpa Medicare Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Shilpa Medicare Limited

Shilpa Medicare Limited is audited by BNPS AND ASSOCIATES LLP (ICAI peer reviewed, certificate valid till 2028-05-31) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
BNPS AND ASSOCIATES LLP (ICAI peer reviewed, certificate valid till 2028-05-31) FY 2026 Declaration of unmodified opinion

Board of Directors of Shilpa Medicare Limited

Shilpa Medicare Limited is currently managed by 6 directors, with 24 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Om Prakash Inani
Also directs: Mohini Infra Private Limited, Srinidhi Cottons Private Limited, Jaijanaki Fabrics Private Limited and 2 more
Director 23 Mar 1988 38 Years 3 Months Current
Kalakota Reddy Sharath
Also directs: Shilpa Pharma Lifesciences Limited, Shilpa Biocare Private Limited
Whole-Time Director 01 Oct 2019 6 Years 9 Months Current
Vishnukanth Chaturbhuj Bhutada
Also directs: Ayodhya Sarayu Infra Llp, Shilpa Pharma Lifesciences Limited, Ftf Pharma Private Limited and 5 more
Managing Director 01 Sep 2015 10 Years 10 Months Current
Hetal Madhukant Gandhi
Also directs: Tia Advisors Llp, Acutaas Chemicals Limited, Syrma Sgs Technology Limited and 5 more
Director 02 Sep 2021 4 Years 10 Months Current
Anita Bandyopadhyay
Also directs: Acutaas Chemicals Limited, Shilpa Pharma Lifesciences Limited, Shilpa Biologicals Private Limited and 2 more
Director 11 Aug 2022 3 Years 11 Months Current
Ashraf Loutfy Abdelhamid Allam Director 13 Aug 2025 0 Years 11 Months Current
View all directors

Financials of Shilpa Medicare Limited FY 2026 filings available

Shilpa Medicare Limited reported revenue of ₹1,538.87 Cr (up 19.62% YoY) for FY 2026.

Revenue · FY 2026
₹1,538.87 Cr ▲ 19.62%
Profit · FY 2026
₹243.33 Cr ▲ 210.79%
Computed EBITDA · FY 2026
₹444.54 Cr ▲ 30.67%
Revenue₹ Cr · Consolidated01,0002,000FY 2020: ₹908 Cr908FY 2020FY 2022: ₹1,146 Cr · +26.2% YoY1,146+26.2%FY 2022FY 2023: ₹1,050 Cr · -8.3% YoY1,050-8.3%FY 2023FY 2024: ₹1,152 Cr · +9.7% YoY1,152+9.7%FY 2024FY 2025: ₹1,286 Cr · +11.7% YoY1,286+11.7%FY 2025FY 2026: ₹1,539 Cr · +19.6% YoY1,539+19.6%FY 2026
Net Profit₹ Cr · Consolidated-1000100200300FY 2020: ₹156 Cr156FY 2020FY 2022: ₹61 Cr · -61.2% YoY60.7-61.2%FY 2022FY 2023: ₹32 Cr (loss) · -153.5% YoY-32.5FY 2023FY 2024: ₹32 Cr · +198.1% YoY31.9+198.1%FY 2024FY 2025: ₹78 Cr · +145.6% YoY78.3+145.6%FY 2025FY 2026: ₹243 Cr · +210.8% YoY243+210.8%FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year0200400600Q1'25: ₹293 Cr · +12.4% YoY293+12.4%Q1'25Q2'25: ₹344 Cr · +9.8% YoY344+9.8%Q2'25Q3'25: ₹319 Cr · +11.5% YoY319+11.5%Q3'25Q4'25: ₹331 Cr · +13.4% YoY331+13.4%Q4'25Q1'26: ₹321 Cr · +9.9% YoY321+9.9%Q1'26Q2'26: ₹370 Cr · +7.6% YoY370+7.6%Q2'26Q3'26: ₹410 Cr · +28.3% YoY410+28.3%Q3'26Q4'26: ₹437 Cr · +32.1% YoY437+32.1%Q4'26
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2020
Revenue from Operations ₹1,538.87 Cr ₹1,286.41 Cr ₹1,151.6 Cr ₹1,050.11 Cr ₹1,145.52 Cr ₹907.91 Cr
Other Income ₹9.84 Cr ₹23.15 Cr ₹8.17 Cr ₹17.4 Cr ₹14.25 Cr ₹16.94 Cr
Total Income ₹1,548.71 Cr ₹1,309.57 Cr ₹1,159.77 Cr ₹1,067.51 Cr ₹1,159.77 Cr ₹924.85 Cr
Cost of Materials Consumed ₹471 Cr ₹350.27 Cr ₹424.32 Cr ₹368.85 Cr ₹381.75 Cr ₹287.02 Cr
Purchases of Stock-in-Trade ₹25.63 Cr ₹22.48 Cr ₹18.01 Cr ₹33.78 Cr ₹8.49 Cr ₹6.76 Cr
Changes in Inventories -₹36.22 Cr ₹37.61 Cr -₹34.78 Cr ₹13.29 Cr -₹7.02 Cr -₹16.05 Cr
Employee Benefit Expense ₹334.88 Cr ₹292.71 Cr ₹281.49 Cr ₹287.33 Cr ₹264.49 Cr ₹196.59 Cr
Finance Costs ₹58.79 Cr ₹75.53 Cr ₹91.81 Cr ₹58.65 Cr ₹41.17 Cr ₹4.56 Cr
Depreciation & Amortisation ₹119.72 Cr ₹112.99 Cr ₹107.87 Cr ₹95.5 Cr ₹79.8 Cr ₹43.78 Cr
Other Expenses ₹308.88 Cr ₹266.29 Cr ₹218.06 Cr ₹244.58 Cr ₹293.96 Cr ₹213.8 Cr
Total Expenses ₹1,282.68 Cr ₹1,157.89 Cr ₹1,106.79 Cr ₹1,101.98 Cr ₹1,062.63 Cr ₹736.45 Cr
Profit Before Exceptional Items & Tax ₹266.03 Cr ₹151.68 Cr ₹52.99 Cr -₹34.47 Cr ₹97.13 Cr ₹188.4 Cr
Exceptional Items ₹29.28 Cr -₹28.08 Cr ₹6.13 Cr ₹0 ₹5.13 Cr -₹35.09 Lakh
Profit Before Tax ₹295.31 Cr ₹123.59 Cr ₹59.12 Cr -₹34.47 Cr ₹102.26 Cr ₹188.05 Cr
Total Tax Expense ₹51.98 Cr ₹44.04 Cr ₹22.39 Cr -₹7.36 Cr ₹41.68 Cr ₹33.49 Cr
Net Profit ₹243.33 Cr ₹78.29 Cr ₹31.87 Cr -₹32.48 Cr ₹60.66 Cr ₹156.15 Cr
  attributable to Owners - ₹0 ₹0 - - -
  attributable to NCI - -₹38,000 ₹0 - - -
Other Comprehensive Income ₹0 -₹2.3 Cr -₹2.37 Cr ₹3.23 Cr -₹1.36 Cr -₹1.05 Cr
Total Comprehensive Income ₹243.33 Cr ₹75.99 Cr ₹29.5 Cr -₹29.25 Cr ₹59.3 Cr ₹155.11 Cr
EBITDA (computed) ₹444.54 Cr ₹340.2 Cr ₹252.67 Cr ₹119.68 Cr ₹218.1 Cr ₹236.74 Cr
Basic EPS ₹12.44 ₹8.04 ₹3.67 ₹3.74 ₹7.26 ₹19.15
Diluted EPS ₹12.44 ₹8.04 ₹3.67 ₹3.74 ₹7.26 ₹19.15
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹3,705.61 Cr ₹3,310.71 Cr ₹3,093.2 Cr ₹2,902.38 Cr
Non-current Assets ₹2,595.84 Cr ₹2,325.04 Cr ₹2,216.38 Cr ₹2,134.37 Cr
Current Assets ₹1,109.77 Cr ₹985.67 Cr ₹876.83 Cr ₹768.01 Cr
Property, Plant & Equipment ₹1,324.34 Cr ₹1,186.04 Cr ₹1,165.92 Cr ₹1,151.48 Cr
Inventories ₹366.79 Cr ₹347.93 Cr ₹344.93 Cr ₹319.82 Cr
Trade Receivables ₹518.85 Cr ₹440.84 Cr ₹392.05 Cr ₹324.35 Cr
Cash & Equivalents ₹41.26 Cr ₹25.97 Cr ₹30.23 Cr ₹21.32 Cr
Equity (Net Worth) ₹2,591.2 Cr ₹2,363.7 Cr ₹1,799.96 Cr ₹1,774.36 Cr
Equity Share Capital ₹19.56 Cr ₹9.78 Cr ₹8.68 Cr ₹8.68 Cr
Borrowings (Non-current) ₹183.81 Cr ₹231.96 Cr ₹560.16 Cr ₹288.82 Cr
Borrowings (Current) ₹474.16 Cr ₹354.41 Cr ₹375.43 Cr ₹506.9 Cr
Total Debt (computed) ₹657.97 Cr ₹586.36 Cr ₹935.59 Cr ₹795.72 Cr
Current Liabilities ₹848.06 Cr ₹674.23 Cr ₹693.35 Cr ₹782.91 Cr
Total Liabilities ₹1,114.41 Cr ₹947.01 Cr ₹1,293.25 Cr ₹1,128.03 Cr
The balance sheet became part of the exchange results-filing format in FY2023 - earlier years were not filed and are hidden.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹342.18 Cr ₹132.18 Cr ₹135.34 Cr ₹226.17 Cr ₹105.13 Cr
Investing Cash Flow -₹325.92 Cr -₹199.08 Cr -₹166.58 Cr -₹278.48 Cr -₹285.5 Cr
Financing Cash Flow ₹13.62 Cr ₹62.65 Cr ₹46.78 Cr ₹45.8 Cr ₹82.86 Cr
Capital Expenditure ₹370.63 Cr ₹243.63 Cr ₹184.56 Cr ₹272.54 Cr ₹331.83 Cr
Free Cash Flow (computed) -₹28.45 Cr -₹111.46 Cr -₹49.22 Cr -₹46.37 Cr -₹226.69 Cr
Dividends Paid ₹9.78 Cr ₹0 ₹0 ₹9.55 Cr ₹8.97 Cr
Net Change in Cash ₹16.61 Cr -₹4.25 Cr ₹11.35 Cr -₹6.51 Cr -₹97.51 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹436.99 Cr ₹409.73 Cr ₹369.97 Cr ₹321.46 Cr ₹330.8 Cr ₹319.32 Cr ₹343.8 Cr ₹292.51 Cr ₹291.69 Cr ₹286.48 Cr ₹312.98 Cr ₹260.17 Cr
Other Income ₹1.67 Cr ₹81.43 Lakh ₹1.75 Cr ₹6.38 Cr ₹7.57 Cr ₹1.13 Cr ₹4.99 Cr ₹9.44 Cr ₹2.49 Cr ₹2.21 Cr ₹1.81 Cr ₹1.93 Cr
Total Income ₹438.66 Cr ₹410.54 Cr ₹371.72 Cr ₹327.84 Cr ₹338.38 Cr ₹320.45 Cr ₹348.79 Cr ₹301.95 Cr ₹294.19 Cr ₹288.7 Cr ₹314.79 Cr ₹262.11 Cr
Cost of Materials Consumed ₹127.57 Cr ₹100.75 Cr ₹127.64 Cr ₹115.04 Cr ₹85.14 Cr ₹89.99 Cr ₹98.43 Cr ₹76.76 Cr ₹101.16 Cr ₹106 Cr ₹122.01 Cr ₹94.85 Cr
Purchases of Stock-in-Trade ₹6.98 Cr ₹7.14 Cr ₹7.36 Cr ₹4.16 Cr ₹6.64 Cr ₹6.7 Cr ₹6.04 Cr ₹2.76 Cr ₹5.36 Cr ₹3.84 Cr ₹4.76 Cr ₹4.06 Cr
Changes in Inventories ₹7.44 Cr ₹25.43 Cr -₹29.5 Cr -₹39.59 Cr ₹12.69 Cr -₹5.68 Cr ₹17.51 Cr ₹13.28 Cr -₹9.44 Cr -₹13.32 Cr -₹97.85 Lakh -₹11.04 Cr
Employee Benefit Expense ₹86.56 Cr ₹83.45 Cr ₹83.05 Cr ₹81.81 Cr ₹70.93 Cr ₹73.49 Cr ₹76.16 Cr ₹72.14 Cr ₹66.46 Cr ₹69.07 Cr ₹73.09 Cr ₹72.88 Cr
Finance Costs ₹13.66 Cr ₹10.68 Cr ₹15.67 Cr ₹18.78 Cr ₹14.49 Cr ₹11.75 Cr ₹25.55 Cr ₹23.74 Cr ₹24.2 Cr ₹26.22 Cr ₹23.24 Cr ₹18.15 Cr
Depreciation & Amortisation ₹30.62 Cr ₹30.36 Cr ₹29.82 Cr ₹28.92 Cr ₹28.79 Cr ₹28.81 Cr ₹28.28 Cr ₹27.11 Cr ₹26.63 Cr ₹26.71 Cr ₹27.79 Cr ₹26.75 Cr
Other Expenses ₹88.73 Cr ₹78.65 Cr ₹73.14 Cr ₹68.4 Cr ₹78.63 Cr ₹74.13 Cr ₹59.65 Cr ₹53.96 Cr ₹58.1 Cr ₹54.95 Cr ₹53.8 Cr ₹51.5 Cr
Total Expenses ₹361.56 Cr ₹336.47 Cr ₹307.18 Cr ₹277.52 Cr ₹297.32 Cr ₹279.18 Cr ₹311.63 Cr ₹269.76 Cr ₹272.46 Cr ₹273.46 Cr ₹303.71 Cr ₹257.15 Cr
Profit Before Exceptional Items & Tax ₹77.1 Cr ₹74.07 Cr ₹64.54 Cr ₹50.31 Cr ₹41.06 Cr ₹41.27 Cr ₹37.16 Cr ₹32.2 Cr ₹21.72 Cr ₹15.23 Cr ₹11.08 Cr ₹4.95 Cr
Exceptional Items ₹43.35 Cr -₹12.86 Cr ₹0 ₹0 -₹28.08 Cr ₹0 ₹0 ₹0 ₹6.13 Cr ₹0 ₹0 ₹0
Profit Before Tax ₹120.45 Cr ₹61.21 Cr ₹64.54 Cr ₹50.31 Cr ₹12.98 Cr ₹41.27 Cr ₹37.16 Cr ₹32.2 Cr ₹27.85 Cr ₹15.23 Cr ₹11.08 Cr ₹4.95 Cr
Total Tax Expense ₹12.66 Cr ₹16.27 Cr ₹20.36 Cr ₹2.69 Cr ₹76.62 Lakh ₹9.83 Cr ₹18.83 Cr ₹14.62 Cr ₹3.21 Cr ₹9.46 Cr ₹7.6 Cr ₹2.11 Cr
Net Profit ₹107.79 Cr ₹44.58 Cr ₹44.07 Cr ₹46.89 Cr ₹14.51 Cr ₹31.78 Cr ₹17.94 Cr ₹14.06 Cr ₹24.5 Cr ₹4.7 Cr ₹1.57 Cr ₹1.18 Cr
  attributable to Owners - ₹0 - ₹0 ₹0 - ₹0 ₹0 ₹0 ₹0 ₹0 ₹1.18 Cr
  attributable to NCI - ₹0 - ₹0 ₹21,000 -₹3,000 ₹0 ₹0 ₹0 -₹12.03 Lakh ₹3.69 Lakh ₹25,000
Other Comprehensive Income ₹0 ₹4.17 Cr -₹3.56 Lakh -₹3.56 Lakh -₹2.39 Cr ₹2.85 Lakh ₹2.85 Lakh ₹2.85 Lakh -₹2.4 Cr -₹1.05 Lakh ₹1.05 Lakh ₹1.05 Lakh
Total Comprehensive Income ₹107.79 Cr ₹48.75 Cr ₹44.03 Cr ₹46.85 Cr ₹12.12 Cr ₹31.81 Cr ₹17.97 Cr ₹14.09 Cr ₹22.1 Cr ₹4.69 Cr ₹1.59 Cr ₹1.19 Cr
EBITDA (computed) ₹121.38 Cr ₹115.11 Cr ₹110.03 Cr ₹98.01 Cr ₹84.34 Cr ₹81.82 Cr ₹91 Cr ₹83.04 Cr ₹72.55 Cr ₹68.16 Cr ₹62.11 Cr ₹49.85 Cr
Basic EPS ₹5.51 ₹2.36 ₹2.25 ₹4.79 ₹1.48 ₹3.25 ₹1.83 ₹1.46 ₹2.82 ₹0.53 ₹0.19 ₹0.14
Diluted EPS ₹5.51 ₹2.36 ₹2.25 ₹4.79 ₹1.48 ₹3.25 ₹1.83 ₹1.46 ₹2.82 ₹0.53 ₹0.19 ₹0.14
Latest 12 quarters shown of 24 on record.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Revenue from Operations ₹597.03 Cr ₹477.34 Cr ₹309.79 Cr ₹247.7 Cr ₹356.95 Cr ₹830.32 Cr ₹805.97 Cr
Other Income ₹38.14 Cr ₹83.83 Cr ₹89.12 Cr ₹68.64 Cr ₹40.86 Cr ₹33.9 Cr ₹11.26 Cr
Total Income ₹635.17 Cr ₹561.18 Cr ₹398.9 Cr ₹316.35 Cr ₹397.81 Cr ₹864.22 Cr ₹817.23 Cr
Cost of Materials Consumed ₹205.99 Cr ₹99.83 Cr ₹73.87 Cr ₹59.12 Cr ₹75.19 Cr ₹303.57 Cr ₹275.9 Cr
Purchases of Stock-in-Trade ₹22.11 Cr ₹14.68 Cr ₹12.75 Cr ₹15.51 Cr ₹6.78 Cr ₹7.81 Cr ₹3.93 Cr
Changes in Inventories -₹3.64 Cr ₹6 Cr ₹2.63 Cr ₹7.56 Cr -₹3.18 Cr -₹54.79 Cr -₹14.26 Cr
Employee Benefit Expense ₹110.99 Cr ₹99.61 Cr ₹103.64 Cr ₹110.45 Cr ₹110.57 Cr ₹175.62 Cr ₹149.28 Cr
Finance Costs ₹10.04 Cr ₹6.6 Cr ₹17.26 Cr ₹20.83 Cr ₹9.05 Cr ₹17.47 Cr ₹4.33 Cr
Depreciation & Amortisation ₹55.11 Cr ₹48.86 Cr ₹49.61 Cr ₹46.55 Cr ₹34.82 Cr ₹40.85 Cr ₹34.96 Cr
Other Expenses ₹105.86 Cr ₹132.63 Cr ₹90.6 Cr ₹99.05 Cr ₹145.91 Cr ₹171.09 Cr ₹146.22 Cr
Total Expenses ₹506.46 Cr ₹408.2 Cr ₹350.36 Cr ₹359.08 Cr ₹379.14 Cr ₹661.63 Cr ₹600.35 Cr
Profit Before Exceptional Items & Tax ₹128.71 Cr ₹152.98 Cr ₹48.54 Cr -₹42.73 Cr ₹18.68 Cr ₹202.59 Cr ₹216.88 Cr
Exceptional Items ₹19.42 Cr -₹45.74 Cr -₹10.45 Cr -₹15.55 Cr ₹8.81 Cr ₹52.95 Cr -₹4.54 Cr
Profit Before Tax ₹148.13 Cr ₹107.24 Cr ₹38.09 Cr -₹58.28 Cr ₹27.49 Cr ₹255.54 Cr ₹212.34 Cr
Total Tax Expense ₹15.16 Cr ₹37.43 Cr ₹11.15 Cr -₹8.79 Cr ₹7.33 Cr ₹71.15 Cr ₹44.15 Cr
Net Profit ₹132.97 Cr ₹69.8 Cr ₹26.94 Cr ₹57.19 Cr ₹140.99 Cr ₹184.39 Cr ₹193.72 Cr
Other Comprehensive Income -₹11 Lakh -₹1.94 Cr -₹1.66 Cr ₹0 -₹1.19 Cr ₹1.79 Lakh -₹1.2 Cr
Total Comprehensive Income ₹132.86 Cr ₹67.86 Cr ₹25.28 Cr ₹57.19 Cr ₹139.8 Cr ₹184.41 Cr ₹192.52 Cr
EBITDA (computed) ₹193.86 Cr ₹208.44 Cr ₹115.41 Cr ₹24.64 Cr ₹62.55 Cr ₹260.91 Cr ₹256.17 Cr
Basic EPS ₹6.80 ₹7.16 ₹3.10 ₹-5.70 ₹2.41 ₹22.62 ₹20.63
Diluted EPS ₹6.80 ₹7.16 ₹3.10 ₹-5.70 ₹2.41 ₹22.62 ₹20.63
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹3,028.55 Cr ₹3,006.66 Cr ₹2,418.59 Cr ₹2,517.36 Cr
Non-current Assets ₹2,502.29 Cr ₹2,529.38 Cr ₹2,041.66 Cr ₹1,882.41 Cr
Current Assets ₹526.26 Cr ₹477.29 Cr ₹376.93 Cr ₹634.95 Cr
Property, Plant & Equipment ₹462.87 Cr ₹440.61 Cr ₹483.46 Cr ₹495.63 Cr
Inventories ₹175.03 Cr ₹148.58 Cr ₹111.92 Cr ₹94.5 Cr
Trade Receivables ₹222.66 Cr ₹190.52 Cr ₹143.82 Cr ₹111.9 Cr
Cash & Equivalents ₹9.15 Cr ₹3.29 Cr ₹2.92 Cr ₹4.58 Cr
Equity (Net Worth) ₹2,713.38 Cr ₹2,700.59 Cr ₹2,142.72 Cr ₹2,117.58 Cr
Equity Share Capital ₹19.56 Cr ₹9.78 Cr ₹8.68 Cr ₹8.68 Cr
Borrowings (Non-current) ₹14.29 Cr ₹24.47 Cr ₹16.25 Cr ₹122.8 Cr
Borrowings (Current) ₹115.71 Cr ₹82.43 Cr ₹126.3 Cr ₹164.61 Cr
Total Debt (computed) ₹130 Cr ₹106.9 Cr ₹142.55 Cr ₹287.42 Cr
Current Liabilities ₹276.42 Cr ₹226.89 Cr ₹226.34 Cr ₹241.41 Cr
Total Liabilities ₹315.17 Cr ₹306.07 Cr ₹275.87 Cr ₹399.77 Cr
The balance sheet became part of the exchange results-filing format in FY2023 - earlier years were not filed and are hidden.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹60 Cr -₹19.06 Cr ₹8.03 Cr ₹2.08 Cr ₹173.87 Cr
Investing Cash Flow -₹67.15 Cr -₹433.29 Cr ₹155.82 Cr -₹94.8 Cr -₹378.97 Cr
Financing Cash Flow ₹13.76 Cr ₹450.09 Cr -₹163.07 Cr ₹87.68 Cr ₹97.23 Cr
Capital Expenditure ₹127.44 Cr ₹57.44 Cr ₹55.08 Cr ₹58.27 Cr ₹173.45 Cr
Free Cash Flow (computed) -₹67.44 Cr -₹76.5 Cr -₹47.05 Cr -₹56.19 Cr ₹41.52 Lakh
Dividends Paid ₹9.78 Cr ₹0 ₹0 ₹9.55 Cr ₹8.97 Cr
Net Change in Cash ₹6.11 Cr -₹2.26 Cr ₹78.16 Lakh -₹5.04 Cr -₹107.88 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹201.11 Cr ₹165.7 Cr ₹134.93 Cr ₹92.43 Cr ₹126.15 Cr ₹125.39 Cr ₹129.68 Cr ₹96.12 Cr ₹87.45 Cr ₹63.98 Cr ₹74.61 Cr ₹83.74 Cr
Other Income ₹6.89 Cr ₹11.29 Cr ₹16.94 Cr ₹17.79 Cr ₹14.08 Cr ₹16.83 Cr ₹21.47 Cr ₹31.45 Cr ₹23.25 Cr ₹22.33 Cr ₹22.76 Cr ₹20.78 Cr
Total Income ₹208 Cr ₹176.99 Cr ₹151.88 Cr ₹110.22 Cr ₹140.24 Cr ₹142.21 Cr ₹151.15 Cr ₹127.57 Cr ₹110.7 Cr ₹86.31 Cr ₹97.38 Cr ₹104.52 Cr
Cost of Materials Consumed ₹67.38 Cr ₹54.03 Cr ₹45.73 Cr ₹38.03 Cr ₹34.54 Cr ₹28.97 Cr ₹22.11 Cr ₹14.2 Cr ₹27.13 Cr ₹10.46 Cr ₹22.27 Cr ₹13.77 Cr
Purchases of Stock-in-Trade ₹6.5 Cr ₹6.32 Cr ₹5.46 Cr ₹3.84 Cr ₹5.45 Cr ₹4.33 Cr ₹3.6 Cr ₹1.3 Cr ₹4.12 Cr ₹2.48 Cr ₹3.6 Cr ₹2.56 Cr
Changes in Inventories ₹4.25 Cr ₹11.55 Cr -₹5.28 Cr -₹14.19 Cr ₹6.01 Cr -₹6.07 Cr -₹2.11 Cr ₹8.17 Cr ₹1.23 Cr ₹5.52 Cr -₹7.2 Cr ₹3.08 Cr
Employee Benefit Expense ₹30.01 Cr ₹30.75 Cr ₹28.47 Cr ₹27.68 Cr ₹22.69 Cr ₹23.54 Cr ₹27.02 Cr ₹26.36 Cr ₹24.28 Cr ₹25.34 Cr ₹26.23 Cr ₹27.8 Cr
Finance Costs ₹2.62 Cr ₹2.74 Cr ₹2.44 Cr ₹2.23 Cr ₹2.09 Cr ₹1.38 Cr ₹1.19 Cr ₹1.95 Cr ₹2.71 Cr ₹2.61 Cr ₹5.18 Cr ₹6.76 Cr
Depreciation & Amortisation ₹14.41 Cr ₹13.56 Cr ₹13.15 Cr ₹12.59 Cr ₹12.34 Cr ₹12.2 Cr ₹12.02 Cr ₹12.3 Cr ₹12.29 Cr ₹12.39 Cr ₹12.67 Cr ₹12.26 Cr
Other Expenses ₹33.18 Cr ₹32.04 Cr ₹21.41 Cr ₹20.07 Cr ₹22.23 Cr ₹52.06 Cr ₹36.2 Cr ₹22.14 Cr ₹23.73 Cr ₹23.48 Cr ₹22.42 Cr ₹21.2 Cr
Total Expenses ₹158.35 Cr ₹151 Cr ₹111.39 Cr ₹90.26 Cr ₹105.35 Cr ₹116.4 Cr ₹100.04 Cr ₹86.42 Cr ₹95.49 Cr ₹82.28 Cr ₹85.17 Cr ₹87.42 Cr
Profit Before Exceptional Items & Tax ₹49.65 Cr ₹25.99 Cr ₹40.49 Cr ₹19.97 Cr ₹34.89 Cr ₹25.82 Cr ₹51.12 Cr ₹41.15 Cr ₹15.21 Cr ₹4.03 Cr ₹12.21 Cr ₹17.1 Cr
Exceptional Items ₹28.37 Cr -₹2.2 Cr -₹1.57 Cr -₹5.18 Cr -₹44.32 Cr -₹48.63 Lakh -₹47.14 Lakh -₹46 Lakh -₹3.78 Cr -₹11.83 Lakh -₹21.17 Lakh -₹6.34 Cr
Profit Before Tax ₹78.02 Cr ₹23.79 Cr ₹38.92 Cr ₹14.79 Cr -₹9.43 Cr ₹25.33 Cr ₹50.65 Cr ₹40.69 Cr ₹11.43 Cr ₹3.91 Cr ₹11.99 Cr ₹10.76 Cr
Total Tax Expense ₹7.05 Cr ₹7.85 Cr ₹8.1 Cr -₹5.91 Cr -₹4.28 Cr ₹9.21 Cr ₹20.16 Cr ₹12.34 Cr ₹1.69 Cr ₹1.21 Cr ₹5.39 Cr ₹2.86 Cr
Net Profit ₹70.97 Cr ₹15.93 Cr ₹30.83 Cr ₹20.7 Cr -₹5.15 Cr ₹16.12 Cr ₹30.49 Cr ₹28.35 Cr ₹9.74 Cr ₹2.7 Cr ₹6.6 Cr ₹7.9 Cr
Other Comprehensive Income -₹1 Lakh -₹9.41 Lakh ₹0 ₹0 -₹1.94 Cr ₹0 ₹0 ₹0 -₹1.66 Cr ₹0 ₹0 ₹0
Total Comprehensive Income ₹70.96 Cr ₹15.84 Cr ₹30.83 Cr ₹20.7 Cr -₹7.1 Cr ₹16.12 Cr ₹30.49 Cr ₹28.35 Cr ₹8.08 Cr ₹2.7 Cr ₹6.6 Cr ₹7.9 Cr
EBITDA (computed) ₹66.68 Cr ₹42.3 Cr ₹56.08 Cr ₹34.79 Cr ₹49.32 Cr ₹39.39 Cr ₹64.33 Cr ₹55.4 Cr ₹30.21 Cr ₹19.03 Cr ₹30.05 Cr ₹36.12 Cr
Basic EPS ₹3.63 ₹0.84 ₹1.58 ₹2.12 ₹-0.53 ₹1.65 ₹3.12 ₹2.94 ₹1.12 ₹0.31 ₹0.76 ₹0.91
Diluted EPS ₹3.63 ₹0.84 ₹1.58 ₹2.12 ₹-0.53 ₹1.65 ₹3.12 ₹2.94 ₹1.12 ₹0.31 ₹0.76 ₹0.91
Latest 12 quarters shown of 25 on record.
Want more history and ratios?
You're viewing the latest exchange-filed financials for Shilpa Medicare Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Shilpa Medicare Limited

As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 40.13%, foreign institutional investors hold 11.08%, domestic institutional investors hold 8.58%, retail and other public shareholders hold 40.21% of Shilpa Medicare Limited. The company had 53,410 shareholders on record.

Promoters: 40.13%DII (Domestic Institutional): 8.58%FII (Foreign Institutional): 11.08%Retail & Others: 40.21%
Mar 2026
QUARTER
40.13% Promoters
8.58% DII (Domestic Institutional)
11.08% FII (Foreign Institutional)
40.21% Retail & Others
Promoter holding - history
Now 40.13% · Mar 2026High 56.89% · Jun 2016Low 40.13% · Dec 2025
39%43.8%48.5%53.3%58%Dec 2015Jun 2018Dec 2020Mar 2023Jun 2025Dec 2015: 53.05%Mar 2016: 53.05%Jun 2016: 56.89%Sep 2016: 56.89%Dec 2016: 54.74%Mar 2017: 54.74%Jun 2017: 54.74%Sep 2017: 54.74%Dec 2017: 53.80%Mar 2018: 53.80%Jun 2018: 53.80%Sep 2018: 53.80%Dec 2018: 53.80%Mar 2019: 53.80%Jun 2019: 53.80%Sep 2019: 53.80%Dec 2019: 53.80%Mar 2020: 53.80%Jun 2020: 53.80%Sep 2020: 53.25%Dec 2020: 53.25%Mar 2021: 53.25%Jun 2021: 53.25%Sep 2021: 53.25%Nov 2021: 50.01%Dec 2021: 50.01%Mar 2022: 50.01%Jun 2022: 50.01%Sep 2022: 50.01%Dec 2022: 50.01%Mar 2023: 50.01%Jun 2023: 50.01%Sep 2023: 50.01%Dec 2023: 50.01%Mar 2024: 50.01%Apr 2024: 44.39%Jun 2024: 44.39%Sep 2024: 44.33%Dec 2024: 44.23%Mar 2025: 44.23%Jun 2025: 44.23%Sep 2025: 44.23%Dec 2025: 40.13%Mar 2026: 40.13%56.89%40.13%40.13%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Promoters40.13%40.13%44.23%44.23%44.23%44.23%
Public59.87%59.87%55.77%55.77%55.77%55.77%
Shareholding history - year on year (as at 31 March)
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016
Promoters40.13%44.23%50.01%50.01%50.01%53.25%53.80%53.80%53.80%54.74%53.05%
Public59.87%55.77%49.99%49.99%49.99%46.75%46.20%46.20%46.20%45.26%46.95%
Promoter change (YoY, %pts)-4.10-5.78+0.00+0.00-3.24-0.55+0.00+0.00-0.94+1.69-

Board & Governance of Shilpa Medicare Limited

As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Shilpa Medicare Limited has 6 directors - 3 independent and 2 executive. The board is chaired by OM PRAKASH INNANI.

DirectorPositionOn board sinceListed boards
OM PRAKASH INNANI Non-Executive - Non Independent Director · Chairperson 1988-03-23 1
VISHNUKANT CHATURBHUJ BHUTADA Executive Director · MD 1987-11-20 1
SHARATH REDDY KALAKOTA Executive Director 2019-10-01 1
HETAL MADHUKANT GANDHI Non-Executive - Independent Director 2021-09-02 6
ANITA BANDYOPADHYAY Non-Executive - Independent Director 2022-09-28 3
ASHRAF LOUTFY ABDELHAMID ALLAM Non-Executive - Independent Director 2025-08-13 1
Board Committees
CommitteeMembers
Audit Committee HETAL MADHUKANT GANDHI (Chairperson), OM PRAKASH INNANI, ANITA BANDYOPADHYAY, ASHRAF LOUTFY ABDELHAMID ALLAM
Nomination and remuneration committee ANITA BANDYOPADHYAY (Chairperson), OM PRAKASH INNANI, HETAL MADHUKANT GANDHI
Stakeholders Relationship Committee OM PRAKASH INNANI (Chairperson), VISHNUKANT CHATURBHUJ BHUTADA, ANITA BANDYOPADHYAY
Risk Management Committee VISHNUKANT CHATURBHUJ BHUTADA, SHARATH REDDY KALAKOTA, ASHRAF LOUTFY ABDELHAMID ALLAM
Corporate Social Responsibility Committee ANITA BANDYOPADHYAY (Chairperson), VISHNUKANT CHATURBHUJ BHUTADA, SHARATH REDDY KALAKOTA

Group Structure of Shilpa Medicare Limited

Shilpa Medicare Limited has 7 subsidiary companies, 2 joint ventures, and 1 associated company. This group structure data is as of FY 2023. The corporate group structure reflects Shilpa Medicare Limited's business expansion strategy and organizational complexity.

7
Subsidiary companies
2
Joint ventures
1
Associated companies
Key Subsidiaries
Company Name CIN Shares Held
Shilpa Pharma Lifesciences Limited U24100KA2020PLC134081 -
Ftf Pharma Private Limited U24230GJ2012PTC070818 -
Shilpa Biologicals Private Limited U24230KA2020PTC131456 -
Shilpa Therapeutics Private Limited U24239KA2004PTC176079 -
Vegil Labs Private Limited U24290KA2021PTC148960 -
Shilpa Biocare Private Limited U24304KA2020PTC131457 -

Showing major subsidiaries. Total: 7.

Charges & Borrowings of Shilpa Medicare Limited

Open charges
₹122.8 Cr
Satisfied charges
₹1,670.23 Cr
Breakdown by lending institutions
Axis Bank Limited₹70.06 Cr
Others₹50.00 Cr
Canara Bank₹2.50 Cr
Standard Chartered Bank₹0.14 Cr
Lakshmi Vilas Bank Limited₹0.10 Cr
Latest charge details
DateLenderAmountStatus
21 Aug 2024 Others ₹50 Cr Open
27 Mar 2023 Standard Chartered Bank ₹14 Lakh Open
27 Feb 2023 Axis Bank Limited ₹70 Cr Open
13 Aug 2021 Axis Bank Limited ₹6.3 Lakh Open
11 May 2020 Canara Bank ₹15.28 Lakh Open

Total charge records: 51 View all charges

Employees and EPFO Compliance at Shilpa Medicare Limited

Shilpa Medicare Limited has a workforce of 930 employees as of Apr 03, 2024.

Employee count
930
Active EPFO establishments
6
Employee growth
-38.65%
Premium access

Employee and EPFO history for Shilpa Medicare Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Shilpa Medicare Limited

Premium access

GST registrations and filing compliance for Shilpa Medicare Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Shilpa Medicare Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Shilpa Medicare Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Shilpa Medicare Limited

Premium access

MSME payment history for Shilpa Medicare Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Shilpa Medicare Limited

Premium access

Corporate group structure for Shilpa Medicare Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Shilpa Medicare Limited

Premium access

MCA filings and documents for Shilpa Medicare Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Shilpa Medicare Limited

Activity
23 Sep 2025
Shilpa Medicare Limited last Annual general meeting of members was held on 23 Sep 2025 as per latest MCA records.
Charges
03 Sep 2025
A charge registered on 04 Aug 2023 via Charge ID 100786136 with Others was fully satisfied on 03 Sep 2025.
Directors
13 Aug 2025
Ashraf Loutfy Abdelhamid Allam was appointed as a Director on 13 Aug 2025 & has been associated with this company since 11 months 7 days.
Activity
31 Mar 2025
Shilpa Medicare Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Charges
21 Aug 2024
A charge with Others amounted to Rs. 50.00 Cr with Charge ID 100981426 was registered on 21 Aug 2024.
Charges
05 Jul 2024
A charge registered on 29 Sep 2022 via Charge ID 100618299 with Idbi Bank Limited was fully satisfied on 05 Jul 2024.

Recent News on Shilpa Medicare Limited

Stocks that will see action today: March 17, 2025
17 Mar 2025 · Thehindubusinessline

Frequently Asked Questions about Shilpa Medicare Limited

Shilpa Medicare Limited is an active public limited company in the pharma sector based in Raichur, Karnataka, India. It was incorporated on 20 November 1987 (39+ years old) and is registered under CIN L85110KA1987PLC008739. Listed on BSE: 530549 and NSE: SHILPAMED. The company has 930 employees.

Shilpa Medicare Limited reported revenue of ₹1,538.87 Cr for FY 2026 (up 19.62% YoY) based on consolidated NSE filings.

The current directors of Shilpa Medicare Limited are:

The primary industry of Shilpa Medicare Limited is pharma. The company specifically operates in pharma contract r and d. The company is currently active in this sector.

Yes. Shilpa Medicare Limited is listed on both BSE (code: 530549) and NSE (symbol: SHILPAMED).

Shilpa Medicare Limited can be reached at the registered office: #12 – 6 – 214A1 Hyderabad Road, Raichur, Karnataka, India – 584135, or through the website vbshilpa.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available